Hypogonadotropism

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-09-03
Clinical Trial Update: A Dose Ranging Study to Examine TDS-Testosterone 5% [Phase 2]
A Phase 2 dose-ranging study of TDS-Testosterone 5% for hypogonadotropism is described; recruitment has not yet begun.